Bristol-Myers' strategy, BD chief Paul Biondi exited the company — just ahead of the $74B Celgene deal close
Paul Biondi, who orchestrated billions of dollars in deals for Bristol-Myers Squibb over the 5 years he’s run their business development team, has exited the company. Biondi left last month, according to a company spokesperson, in pursuit of another — unspecified — external opportunity.
After 17 years with Bristol-Myers Squibb, Paul Biondi, Head of Strategy and Business Development, decided to leave the company to pursue an external opportunity. The company wishes him well in his new endeavors. Bristol-Myers Squibb is actively searching for Paul’s successor, and will make an announcement, as appropriate.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 87,700+ biopharma pros reading Endpoints daily — and it's free.